Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB–IV
Keywords: لونافنریب; Ovarian cancer; Phase II trial; Lonafarnib; Farnesytransferase inhibition; Firstline treatment